DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jack Dorsey — - 2 Elon - 1 X - 1 Musk — - 1 Narendra Modi's - 1 Modi - 1 Musk - 1 Naman Tandon - 1
Top related locs:
Punjab Haryana Ambala India New Delhi Delhi Pakistan Sri Lanka
Top related orgs:
Twitter - 2 Global Government Affairs - 1 CNBC - 1 country's Ministry of Information - 1 Broadcasting - 1 European Union - 1 Bloomberg - 1 Meta - 1

Search resuls for: "Jack Dorsey —"


6 mentions found


☆ Elon Musk's X suspends some India accounts after order from Modi government
  + stars: | 2024-02-22 | by ( Charmaine Jacob | In Charmainemariajacob | ) www.cnbc.com   time to read: +3 min
Elon Musk's social media platform X said Thursday it will block certain accounts and posts from India in response to executive orders by the government. X said it did not agree with the order but failure to comply would subject the company to "potential penalties including significant fines and imprisonment." Tens of thousands of Indian farmers — mostly from the northern state of Punjab — have been protesting since mid-February in renewed calls for better crop prices which were promised to them in 2021. In October, the Modi government warned Musk that X would have to comply to country's new and upcoming IT rules. However, it has written an appeal challenging the Indian government with accounts that are pending to be blocked, the company said.
Persons: Elon, X, Jack Dorsey —, Musk —, Narendra Modi's, Modi, Musk, Naman Tandon Organizations: Global Government Affairs, CNBC, country's Ministry of Information, Broadcasting, Reuters, Twitter Locations: Punjab, Haryana, Ambala, India, New Delhi, Delhi, Pakistan, Sri Lanka
☆ Mark Zuckerberg just launched the Twitter killer Threads app and wants to get '1 billion+ people on it'
  + stars: | 2023-07-06 | by ( Huileng Tan | Kai Xiang Teo | ) www.businessinsider.com   time to read: +3 min
Over 5 million users signed up for Threads in the first four hours of its launch, per Meta CEO Mark Zuckerberg. Meta CEO Mark Zuckerberg ratcheted his rivalry with Twitter owner Elon Musk as Meta rolled out its Threads app to users in 100 countries on Wednesday. Over five million users signed up for the app in the first four hours of its launch, Zuckerberg posted on Threads. The app somewhat resembles Twitter, leading Zuckerberg to post his first tweet in a decade — the famed Spider-Man pointing at Spider-Man meme. To be sure, Meta's Threads isn't the only game in town trying to the Twitter Killer.
Persons: —, Mark Zuckerberg, Elon Musk, Zuckerberg, hasn't, Meta, Instagram, Billy Duberstein, Jack Dorsey —, Donald Trump's, Matthew Loh, Duberstein, Insider's Sydney Bradley, Amanda Perelli Organizations: Twitter, European Union, Bloomberg, Meta, Stone Oak Capital
☆ Short sellers haven't profited a lot from Hindenburg Research's salvo against Carl Icahn's investment firm
  + stars: | 2023-05-04 | by ( Zinya Salfiti | ) www.businessinsider.com   time to read: +2 min
Short sellers haven't profited significantly from Hindenburg Research's recent report against Icahn Enterprises. That's because Wall Street investors remain hesitant to place bets against the billionaire owner Carl Icahn, Bloomberg reported. Short sellers have made just $9 million in mark-to-market profit, per S3 Partners data. Hindenburg also alleged that the company is "using money taken in from new investors to pay out dividends to old investors." The short seller's report on Gautam Adani's company shaved tens of billions off of its market cap and dealt a huge blow to the billionaire's net worth.
☆ Activist investor Carl Icahn's wealth plunged by $10 billion after a short-seller accused his company of running a 'Ponzi-like' structure
  + stars: | 2023-05-03 | by ( Huileng Tan | ) www.businessinsider.com   time to read: +3 min
Hindenburg Research released a report alleging "Ponzi-like" economic structures at Icahn Enterprises. Shares of Icahn Enterprises closed 20% lower at $40.36 on Tuesday. Activist investor Carl Icahn's wealth plunged by $10 billion on Tuesday after Hindenburg Research — a short-seller that took on one of Asia's richest men earlier this year — targeted Icahn Enterprises with a scathing report. As Icahn derives his wealth from an 89% stake in Icahn Enterprises, his fortune was hit by the rout. Insider was unable to reach Icahn Enterprises via phone outside regular business hours.
☆ Report claims 'criminal activity and fraud run rampant' on Cash App—what users need to know
  + stars: | 2023-03-24 | by ( Kamaron Mcnair | ) www.cnbc.com   time to read: +1 min
A new report from Hindenburg Research, a short seller investment firm, released Thursday has accused Block — the company formerly known as Square, founded by Jack Dorsey — of allowing crime and fraud to "run rampant" on its peer-to-peer payment app, Cash App. The report alleged that Block inflated its customer growth, allowed fake accounts to thrive and dodged revenue regulations — an accusation that triggered a Securities Exchange Commission (SEC) investigation. Hindenburg claims it was able to open fake accounts on Cash App under names Donald Trump and Elon Musk. Block called the report "factually inaccurate" in a statement, and says it is complying with the SEC and exploring legal action against Hindenburg. It's worth noting last March, Block revealed it was the subject of a Consumer Financial Protection Bureau (CFPB) investigation over the way Cash App handles user complaints.
☆ OpenAI CEO Sam Altman takes diabetes drug metformin as part of his anti-aging routine
  + stars: | 2023-03-08 | by ( Aaron Mok | ) www.businessinsider.com   time to read: +3 min
OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. Metformin is a decades-old drug that is prescribed to millions of people with diabetes, CNBC reported. In addition to the drug, Altman's said his anti-aging regimen includes "trying to eat healthy, exercise, and sleep enough," per the MIT Technology Review. The company uses genetic engineering and plasma replacement to make cells younger, per the MIT Technology Review. Altman secretly poured $180 million dollars into Retro Bioscience's death-delaying treatment, the MIT Technology Review reported.
0 next >>
Total: 6